These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22406115)

  • 1. Discovery of a new binding mode for a series of liver X receptor agonists.
    Kopecky DJ; Jiao XY; Fisher B; McKendry S; Labelle M; Piper DE; Coward P; Shiau AK; Escaron P; Danao J; Chai A; Jaen J; Kayser F
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2407-10. PubMed ID: 22406115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) β Agonist.
    Zheng Y; Zhuang L; Fan KY; Tice CM; Zhao W; Dong C; Lotesta SD; Leftheris K; Lindblom PR; Liu Z; Shimada J; Noto PB; Meng S; Hardy A; Howard L; Krosky P; Guo J; Lipinski K; Kandpal G; Bukhtiyarov Y; Zhao Y; Lala D; Van Orden R; Zhou J; Chen G; Wu Z; McKeever BM; McGeehan GM; Gregg RE; Claremon DA; Singh SB
    J Med Chem; 2016 Apr; 59(7):3264-71. PubMed ID: 26990539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting selective liver X receptor β agonists using multiple machine learning methods.
    Li Y; Wang L; Liu Z; Li C; Xu J; Gu Q; Xu J
    Mol Biosyst; 2015 May; 11(5):1241-50. PubMed ID: 25734698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 24(S)-Saringosterol from edible marine seaweed Sargassum fusiforme is a novel selective LXRβ agonist.
    Chen Z; Liu J; Fu Z; Ye C; Zhang R; Song Y; Zhang Y; Li H; Ying H; Liu H
    J Agric Food Chem; 2014 Jul; 62(26):6130-7. PubMed ID: 24927286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The medicinal chemistry of liver X receptor (LXR) modulators.
    Tice CM; Noto PB; Fan KY; Zhuang L; Lala DS; Singh SB
    J Med Chem; 2014 Sep; 57(17):7182-205. PubMed ID: 24832115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyanidin, a natural flavonoid, is an agonistic ligand for liver X receptor alpha and beta and reduces cellular lipid accumulation in macrophages and hepatocytes.
    Jia Y; Hoang MH; Jun HJ; Lee JH; Lee SJ
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4185-90. PubMed ID: 23769638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of new liver X receptor agonists by pharmacophore modeling and shape-based virtual screening.
    Temml V; Voss CV; Dirsch VM; Schuster D
    J Chem Inf Model; 2014 Feb; 54(2):367-71. PubMed ID: 24502802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-ray structures of the LXRalpha LBD in its homodimeric form and implications for heterodimer signaling.
    Fradera X; Vu D; Nimz O; Skene R; Hosfield D; Wynands R; Cooke AJ; Haunsø A; King A; Bennett DJ; McGuire R; Uitdehaag JC
    J Mol Biol; 2010 May; 399(1):120-32. PubMed ID: 20382159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 4-(3-biaryl)quinoline sulfones as potent liver X receptor agonists.
    Ullrich JW; Morris R; Bernotas RC; Travins JM; Jetter J; Unwalla R; Quinet E; Nambi P; Feingold I; Huselton C; Enroth C; Wilhelmsson A; Goos-Nilsson A; Wrobel J
    Bioorg Med Chem Lett; 2010 May; 20(9):2903-7. PubMed ID: 20382019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver X receptor (LXR) partial agonists: biaryl pyrazoles and imidazoles displaying a preference for LXRβ.
    Kick E; Martin R; Xie Y; Flatt B; Schweiger E; Wang TL; Busch B; Nyman M; Gu XH; Yan G; Wagner B; Nanao M; Nguyen L; Stout T; Plonowski A; Schulman I; Ostrowski J; Kirchgessner T; Wexler R; Mohan R
    Bioorg Med Chem Lett; 2015 Jan; 25(2):372-7. PubMed ID: 25435151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and discovery of 2-oxochromene derivatives as liver X receptor β-selective agonists.
    Matsuda T; Okuda A; Watanabe Y; Miura T; Ozawa H; Tosaka A; Yamazaki K; Yamaguchi Y; Kurobuchi S; Koura M; Shibuya K
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1274-8. PubMed ID: 25677664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship-guided development of retinoic acid receptor-related orphan receptor gamma (RORγ)-selective inverse agonists with a phenanthridin-6(5H)-one skeleton from a liver X receptor ligand.
    Nishiyama Y; Nakamura M; Misawa T; Nakagomi M; Makishima M; Ishikawa M; Hashimoto Y
    Bioorg Med Chem; 2014 May; 22(9):2799-808. PubMed ID: 24702856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboxylic acid based quinolines as liver X receptor modulators that have LXRbeta receptor binding selectivity.
    Hu B; Quinet E; Unwalla R; Collini M; Jetter J; Dooley R; Andraka D; Nogle L; Savio D; Halpern A; Goos-Nilsson A; Wilhelmsson A; Nambi P; Wrobel J
    Bioorg Med Chem Lett; 2008 Jan; 18(1):54-9. PubMed ID: 18023179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a selective agonist for liver X receptor α (LXRα) via screening of a synthetic compound library.
    Li N; Xu Y; Feng T; Liu C; Li Y; Wang X; Si S
    J Biomol Screen; 2014 Apr; 19(4):566-74. PubMed ID: 24334278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
    Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
    Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different regulation of the LXRalpha promoter activity by isoforms of CCAAT/enhancer-binding proteins.
    Steffensen KR; Schuster GU; Parini P; Holter E; Sadek CM; Cassel T; Eskild W; Gustafsson JA
    Biochem Biophys Res Commun; 2002 May; 293(5):1333-40. PubMed ID: 12054659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and Synthesis of a Novel Series of Liver X Receptor Antagonists.
    Nian S; Gan X; Tan X; Yu Z; Wang P; Chen X; Wang G
    Chem Pharm Bull (Tokyo); 2015; 63(8):628-35. PubMed ID: 26062802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver X receptor beta with mutations in the activation function-2 region is excluded from the nucleolus.
    Lall R; Kuruvilla S; Prüfer K
    Cell Biol Int; 2009 Mar; 33(3):447-52. PubMed ID: 19356704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of alpha-glucosidase-inhibitory and liver X receptor-antagonistic activities of phenethylphenyl phthalimide analogs and generation of LXRalpha-selective antagonists.
    Motoshima K; Noguchi-Yachide T; Sugita K; Hashimoto Y; Ishikawa M
    Bioorg Med Chem; 2009 Jul; 17(14):5001-14. PubMed ID: 19539483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional pharmacophore modeling of liver-X receptor agonists.
    Zhao W; Gu Q; Wang L; Ge H; Li J; Xu J
    J Chem Inf Model; 2011 Sep; 51(9):2147-55. PubMed ID: 21434646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.